NASDAQ:IOSP - Innospec Stock Price, Forecast & News

Innospec trades on the NASDAQ under the ticker symbol "IOSP."

Innospec announced a Semi-Annual dividend on Tuesday, November 5th. Stockholders of record on Tuesday, November 19th will be given a dividend of $0.52 per share on Wednesday, November 27th. The ex-dividend date of this dividend is Monday, November 18th. This is a positive change from Innospec's previous Semi-Annual dividend of $0.50. View Innospec's Dividend History.

Innospec Inc. (NASDAQ:IOSP) issued its quarterly earnings results on Tuesday, November, 5th. The specialty chemicals company reported $1.40 earnings per share (EPS) for the quarter, topping the Zacks' consensus estimate of $1.25 by $0.15. The specialty chemicals company had revenue of $371.90 million for the quarter, compared to analysts' expectations of $367.65 million. Innospec had a return on equity of 15.52% and a net margin of 6.69%. Innospec's quarterly revenue was up 2.4% on a year-over-year basis. During the same period in the prior year, the company posted $1.20 EPS. View Innospec's Earnings History.

Innospec is scheduled to release their next quarterly earnings announcement on Tuesday, February 18th 2020. View Earnings Estimates for Innospec.

Innospec will be holding an earnings conference call on Tuesday, February 18th at 12:00 AM Eastern. Interested parties can register for or listen to the call using this link or dial in at Not Available.

1 analysts have issued twelve-month target prices for Innospec's stock. Their forecasts range from $95.00 to $95.00. On average, they expect Innospec's stock price to reach $95.00 in the next year. This suggests that the stock has a possible downside of 11.0%. View Analyst Price Targets for Innospec.

1 Wall Street analysts have issued "buy," "hold," and "sell" ratings for Innospec in the last year. There are currently 1 buy rating for the stock, resulting in a consensus recommendation of "Buy." View Analyst Ratings for Innospec.

News articles about IOSP stock have trended somewhat negative on Friday, according to InfoTrie. The research group identifies negative and positive media coverage by reviewing more than six thousand blog and news sources. The firm ranks coverage of publicly-traded companies on a scale of -5 to 5, with scores closest to five being the most favorable. Innospec earned a daily sentiment score of -1.9 on InfoTrie's scale. They also gave news articles about the specialty chemicals company a news buzz of 10.0 out of 10, indicating that recent media coverage is extremely likely to have an effect on the company's share price in the near term. View News Stories for Innospec.

Innospec saw a increase in short interest during the month of December. As of December 13th, there was short interest totalling 354,700 shares, an increase of 32.3% from the November 28th total of 268,200 shares. Based on an average daily volume of 96,000 shares, the days-to-cover ratio is currently 3.7 days. Currently, 1.5% of the shares of the company are short sold. View Innospec's Current Options Chain.

Some companies that are related to Innospec include Ecolab (ECL), Sherwin-Williams (SHW), International Flavors & Fragrances (IFF), Celanese (CE), RPM International (RPM), Albemarle (ALB), NewMarket (NEU), W. R. Grace & Co (GRA), Ashland Global (ASH), Balchem (BCPC), Quaker Chemical (KWR), PolyOne (POL), Sensient Technologies (SXT), HB Fuller (FUL) and Stepan (SCL).

Based on aggregate information from My MarketBeat watchlists, some companies that other Innospec investors own include Intellia Therapeutics (NTLA), Las Vegas Sands (LVS), Altria Group (MO), Exxon Mobil (XOM), NVIDIA (NVDA), Franklin Resources (BEN), Colgate-Palmolive (CL), Eastman Chemical (EMN), Emerson Electric (EMR) and Invesco (IVZ).

Innospec's stock is owned by a variety of of institutional and retail investors. Top institutional shareholders include State of Alaska Department of Revenue (0.08%), Strs Ohio (0.05%), Bowling Portfolio Management LLC (0.04%), Convergence Investment Partners LLC (0.03%), Louisiana State Employees Retirement System (0.03%) and Nisa Investment Advisors LLC (0.02%). Company insiders that own Innospec stock include Brian Watt, Catherine Hessner, David Earl Williams, Hugh Aldous, Ian Cleminson, Ian Malcolm Mcrobbie, Milton C Blackmore, Patrick Williams, Philip Curran and Philip John Boon. View Institutional Ownership Trends for Innospec.

IOSP stock was sold by a variety of institutional investors in the last quarter, including Campbell & CO Investment Adviser LLC, Louisiana State Employees Retirement System, Strs Ohio, State of Alaska Department of Revenue, Diversified Trust Co and Nisa Investment Advisors LLC. Company insiders that have sold Innospec company stock in the last year include Brian Watt, Catherine Hessner, Hugh Aldous, Ian Cleminson, Milton C Blackmore, Patrick Williams, Philip Curran and Philip John Boon. View Insider Buying and Selling for Innospec.

IOSP stock was purchased by a variety of institutional investors in the last quarter, including Bowling Portfolio Management LLC and Convergence Investment Partners LLC. View Insider Buying and Selling for Innospec.

Shares of IOSP can be purchased through any online brokerage account. Popular online brokerages with access to the U.S. stock market include Vanguard Brokerage Services, TD Ameritrade, E*TRADE, Robinhood, Fidelity and Charles Schwab.

One share of IOSP stock can currently be purchased for approximately $106.78.

Innospec has a market capitalization of $2.62 billion and generates $1.48 billion in revenue each year. Innospec employs 2,000 workers across the globe.View Additional Information About Innospec.

The official website for Innospec is http://www.innospecinc.com/.

Innospec's mailing address is 8310 SOUTH VALLEY HIGHWAY SUITE 350, ENGLEWOOD CO, 80112. The specialty chemicals company can be reached via phone at 303-792-5554 or via email at [email protected]